Histophilus Somni (TEME - cattle)

Histophilus somni disease, including its neurological form known as thrombotic meningoencephalitis or TEME, represents one of the most significant bacterial infections affecting cattle in North America. This gram-negative bacterium causes a spectrum of disease ranging from respiratory infections to reproductive failure, but its neurological manifestation is particularly devastating, often progressing from apparent health to death within 24 to 48 hours. The organism's ability to cause widespread vascular damage throughout the body, with particular affinity for brain tissue, makes this one of the most challenging infectious diseases facing the cattle industry.

Histophilus somni primarily affects cattle, though the organism has been isolated from sheep and occasionally other species. Feedlot cattle experiencing the stress of transportation, commingling, and dietary changes face the highest risk, with TEME representing a significant cause of morbidity and mortality in these populations. Dairy calves raised in group housing and beef cattle undergoing any significant stress event are also susceptible. The neurological form of disease may occur as part of outbreaks affecting multiple animals or as sporadic individual cases, making surveillance and prevention challenging.

The economic impact of Histophilus somni infection extends across multiple sectors of the cattle industry through mortality, treatment costs, reduced performance, and prevention program expenses. The neurological form is particularly costly due to the high case fatality rate and the loss of valuable animals that often appeared completely healthy just hours before death. Reproductive losses from Histophilus-associated infertility and abortion add to the economic burden. The organism's role in the bovine respiratory disease complex means that its impact extends beyond discrete clinical episodes to affect overall herd health and production efficiency.

Treatability of the neurological form of Histophilus somni disease is limited by the extremely rapid progression of clinical signs and the extensive vascular damage that occurs early in the disease course. When treatment is initiated before severe neurological involvement develops, antibiotic therapy may be effective. However, the fulminant nature of TEME means that most animals are already severely compromised by the time signs are recognized. Prevention through vaccination, stress reduction, and health management programs offers greater promise than relying on treatment of clinical cases.

Histophilus somni is a gram-negative, pleomorphic bacterium that causes disease through a combination of direct tissue invasion and vascular damage mediated by bacterial products. The organism is commonly found as part of the normal respiratory and genital tract flora of healthy cattle, making the transition from commensal to pathogen dependent on host factors, bacterial virulence, and environmental conditions. Disease occurs when host defenses are compromised and the bacteria proliferate beyond normal levels, enter the bloodstream, and localize in various organs including the brain.

The pathogenic mechanisms of Histophilus somni include several virulence factors that enable tissue invasion and evasion of host immune responses. The bacterium produces lipooligosaccharide that triggers inflammatory responses and damages vascular endothelium. Immunoglobulin-binding proteins help the organism evade antibody-mediated immunity. Phase variation allows the bacteria to modify surface antigens and escape immune recognition. These mechanisms combine to allow Histophilus somni to establish systemic infection despite the presence of normal immune function.

Environmental and management factors strongly influence the likelihood of Histophilus somni disease development. Transportation stress, with its associated crowding, feed and water deprivation, and exposure to novel pathogens, creates ideal conditions for disease transmission and host susceptibility. Commingling cattle from multiple sources increases exposure to diverse Histophilus strains while simultaneously stressing animals. Sudden dietary changes affect ruminal function and may impact systemic immunity. Extremes of weather, either hot or cold, add to physiological stress. These factors explain why feedlot cattle in the weeks following arrival are at particularly high risk.

Certain animals face elevated risk based on age, immune status, and exposure history. Young cattle that have not yet developed immunity through natural exposure or vaccination are most susceptible. Animals experiencing concurrent infections, particularly respiratory viruses that damage mucosal barriers, have compromised defenses against bacterial invasion. Immunosuppression from any cause increases susceptibility. Prior exposure may provide partial protection, which is why animals from endemic areas may show lower disease rates than truly naive populations.

The pathophysiology of thrombotic meningoencephalitis reflects the organism's pronounced tropism for vascular endothelium, particularly in the brain. Following bacteremia, Histophilus somni adheres to the endothelial lining of blood vessels where it causes local inflammation, vasculitis, and thrombosis. In the brain, this vascular damage produces multiple small areas of infarction, hemorrhage, and necrosis, creating the characteristic lesions of TEME. The septicemic nature of infection means that multiple organ systems may be affected simultaneously, with myocarditis, arthritis, pneumonia, and reproductive tract disease occurring alongside or independent of neurological involvement.

Early warning signs of Histophilus somni neurological disease may be brief or absent, with many cases progressing from apparent health to severe illness within hours. When prodromal signs are observed, they include mild depression, decreased feed intake, and subtle changes in behavior that may be easily overlooked in group-housed cattle. Mild fever may be present but is often missed without routine temperature monitoring. A slight reluctance to move or subtle changes in gait may precede more obvious neurological signs. The challenge for managers is recognizing these vague early signs among groups of cattle where individual observation is difficult.

Neurological symptoms develop rapidly once central nervous system involvement occurs. Affected cattle typically show profound depression, standing with a lowered head and exhibiting decreased awareness of their surroundings. The classic 'sleeper' syndrome description refers to animals that appear to be in a stuporous state, slow to respond or completely unresponsive to stimuli. Weakness progresses to recumbency, with animals unable to rise. Fever is usually present, often marked, with temperatures exceeding 106°F in acute cases. The speed of progression distinguishes TEME from many other neurological conditions.

Behavioral changes reflect the diffuse brain involvement characteristic of thrombotic meningoencephalitis. Animals may show blindness, either partial or complete, due to involvement of visual pathways. Hyperesthesia, with exaggerated responses to touch or noise, may alternate with periods of complete unresponsiveness. Head pressing against obstacles indicates increased intracranial pressure. Abnormal jaw movements, bruxism, and drooling may be observed. Some animals show aggression or frenzied behavior during brief periods of apparent arousal before returning to profound depression.

Physical examination findings in TEME cases reveal the systemic nature of the infection beyond just neurological involvement. High fever is typical and may be the most consistent early finding. Respiratory involvement produces increased respiratory rate and effort in many cases. Eye examination may reveal congestion, hemorrhage, or changes in pupillary responses reflecting brain involvement. Heart auscultation may detect murmurs or rhythm disturbances from concurrent myocarditis. Joints may be hot and swollen if polyarthritis is present. The multisystem involvement reflects the septicemic pathogenesis.

Symptom progression in TEME follows a devastating course in most cases. From the first recognition of neurological signs, progression to recumbency typically occurs within hours. Convulsions may develop, with seizures ranging from subtle tremors to violent generalized episodes. Respiratory distress may worsen as brain swelling affects respiratory centers. Coma develops in terminal stages. Many animals die within 24 to 48 hours of first observed signs, and some are simply found dead with no illness having been detected. The peracute nature makes treatment extremely challenging.

Emergency symptoms that warrant immediate intervention include any combination of acute fever, depression, and neurological signs in cattle, particularly feedlot animals in the high-risk period following arrival. Cattle found recumbent and unresponsive represent critical emergencies. Any sudden deaths in groups of cattle should trigger evaluation of pen mates for early signs of TEME. Given the rapid progression and high fatality rate, treatment must be initiated immediately upon suspicion rather than waiting for diagnostic confirmation.

Clinical diagnosis of Histophilus somni neurological disease relies on recognition of the characteristic syndrome in an appropriate epidemiological context. The combination of acute onset fever, profound depression ('sleeper' presentation), and rapid progression to recumbency in feedlot cattle or other high-risk populations creates strong suspicion for TEME. History of recent transportation, commingling, or other stressors supports the diagnosis. The presence of concurrent respiratory disease or polyarthritis in affected or pen mate animals strengthens suspicion. However, the rapid progression means that treatment decisions often must be made based on clinical impression without laboratory confirmation.

Laboratory diagnosis can confirm Histophilus somni infection but is often most useful retrospectively or for herd-level assessment. Blood culture may isolate the organism during the septicemic phase but is not practical for immediate treatment decisions. Cerebrospinal fluid analysis shows changes consistent with bacterial meningitis, including elevated protein and pleocytosis, but CSF collection is not typically performed in field situations. Serological testing can document exposure but does not distinguish current infection from past exposure. Nasal swab culture may isolate the organism but presence on mucosal surfaces does not confirm causation of disease.

Differential diagnosis for acute neurological disease with rapid progression and fever in cattle includes several important conditions. Other bacterial meningoencephalitides including Listeria monocytogenes produce neurological signs but typically with slower onset and more asymmetric presentation. Rabies must be considered in unvaccinated animals, though the disease course differs. Lead poisoning causes neurological signs but without fever and with different historical context. Polioencephalomalacia produces depression and neurological signs but fever is absent and the condition responds to thiamine. Thromboembolism from other sources can produce focal neurological signs.

Post-mortem examination provides the most definitive diagnosis of TEME and should be pursued whenever possible following deaths suspicious for this condition. Gross findings include hemorrhagic infarcts scattered throughout the brain, producing characteristic foci of reddish-brown discoloration visible on cut surface. The distribution of lesions - often bilateral and affecting multiple brain regions - is characteristic. Histopathology reveals vasculitis with thrombosis and surrounding areas of necrosis and hemorrhage. Similar vascular lesions may be present in heart, lungs, and other organs. Bacterial culture from brain tissue confirms Histophilus somni as the causative agent.

Emergency treatment of suspected TEME must be initiated immediately upon suspicion, as delays of even hours may allow progression beyond the point where treatment can succeed. High-dose antibiotic therapy with drugs effective against Histophilus somni represents the cornerstone of treatment. Oxytetracycline, florfenicol, ceftiofur, and tilmicosin are among the antibiotics with activity against this organism. Intravenous or intramuscular administration achieves rapid blood and tissue levels. The goal is to eliminate bacteremia and halt the progression of vascular damage before irreversible brain injury occurs.

Anti-inflammatory therapy complements antibiotic treatment by reducing the inflammatory response that contributes to tissue damage. Non-steroidal anti-inflammatory drugs such as flunixin meglumine address both inflammation and fever. Corticosteroids are sometimes used for their potent anti-inflammatory effects but may compromise immune function. The balance between controlling damaging inflammation and maintaining necessary immune responses requires clinical judgment. Fever reduction through anti-inflammatory therapy also improves animal comfort and may support recovery.

Supportive care for TEME cases addresses the systemic effects of septicemia and the complications of neurological impairment. Fluid therapy corrects dehydration and supports cardiovascular function during the septicemic crisis. Thiamine supplementation is sometimes included as a precaution against polioencephalomalacia, which can present similarly. Nursing care for recumbent animals includes appropriate bedding, positioning, and protection from environmental extremes. Seizure control with appropriate anticonvulsants may be necessary in some cases.

Herd-level interventions when TEME occurs should address both treatment of additional cases and prevention of new infections. Metaphylactic treatment of pen mates with appropriate antibiotics may prevent disease development in animals with subclinical infection. Increased monitoring allows early detection of additional cases when treatment is most likely to succeed. Vaccination, if not already current, should be initiated though protection will not be immediate. Stress reduction through environmental and management modifications may reduce disease progression in incubating animals.

Withdrawal times for all treatments must be carefully observed in food-producing animals. The antibiotics used for TEME treatment have varying meat withdrawal periods that must be documented and followed. Animals that recover must complete the required withdrawal before slaughter. These considerations should not delay necessary treatment, but they must inform the treatment plan and subsequent management decisions. In some cases, the cost of extended feeding through withdrawal periods factors into economic decisions about treatment versus euthanasia.

Treatment outcomes for TEME are generally poor despite appropriate therapy, particularly when neurological signs are advanced at presentation. The vascular damage that produces clinical signs is often irreversible by the time it is detected. Even animals that appear to respond initially may relapse or develop complications. Case fatality rates in diagnosed TEME often exceed 50% even with treatment. This reality should inform expectations when treating suspected cases and reinforce the importance of prevention over reliance on treatment.

Recovery from Histophilus somni neurological disease is possible but relatively uncommon, with outcomes heavily dependent on disease severity at treatment initiation and individual animal response. Animals treated very early in the course, before significant brain damage has occurred, have the best chance of meaningful recovery. Improvement may be evident within 24 to 48 hours of treatment initiation in favorable cases, with gradual return of appetite, alertness, and mobility. Complete recovery may require weeks, and some animals retain permanent neurological deficits.

Post-treatment monitoring must watch for both relapse and the development of sequelae. Fever should resolve within days of initiating appropriate antibiotic therapy; persistent fever suggests treatment failure or a resistant organism. Neurological function should show progressive improvement, with any deterioration indicating a poor prognosis. Animals must be monitored for complications including secondary pneumonia, pressure damage from recumbency, and nutritional compromise. Antibiotic therapy should continue for the full recommended course even if clinical improvement occurs to prevent relapse.

Prognosis factors for Histophilus somni neurological disease include the severity and duration of signs before treatment, the promptness and completeness of treatment response, and the presence of complications or concurrent infections. Animals that remained ambulatory and were treated within hours of first signs have reasonable prognosis. Those that were recumbent for extended periods, experienced seizures, or showed minimal response to initial treatment have poor prognosis. The presence of concurrent organ involvement including severe pneumonia, myocarditis, or widespread septicemia worsens outcomes.

Return to production for the uncommon survivors of TEME requires careful assessment of residual function and productivity. Neurological evaluation should confirm adequate vision, coordination, and behavior for the animal's intended use. Animals with permanent deficits may be unsuitable for breeding programs or require special management. Growth and production performance may be reduced in recovered animals. Meat withdrawal times for antibiotics used in treatment must be completed before animals can be marketed. The economics of maintaining recovered animals through extended recovery and withdrawal periods should be considered.

Vaccination against Histophilus somni represents an important component of prevention programs, particularly for feedlot cattle and other high-risk populations. Several commercial vaccines are available, typically administered as part of combination respiratory disease vaccines. Primary vaccination requires two doses given two to four weeks apart to establish immunity, with timing ideally completed before the period of highest risk. Pre-arrival vaccination of calves before shipment to feedlots provides protection during the stressful transition period. Booster vaccination maintains protection in animals with ongoing risk.

Stress reduction through management practices addresses one of the primary factors enabling Histophilus somni disease development. Minimizing transportation time and providing adequate rest and recovery periods after shipment reduces physiological stress. Gradual dietary transitions avoid the additional stress of sudden feed changes. Proper bunk management ensures all animals have adequate access to feed and water. Avoiding overcrowding reduces both stress and disease transmission. Weather protection limits environmental stress. These fundamental management practices support immune function and reduce disease susceptibility.

Biosecurity measures can limit exposure to Histophilus somni and other respiratory pathogens, though the organism's common presence in healthy cattle makes elimination unrealistic. Avoiding commingling cattle from numerous sources reduces exposure to diverse bacterial strains. Quarantine of new arrivals allows identification of sick animals before exposure to the main population. All-in/all-out management when possible limits continuous transmission chains. Controlling traffic and personnel movement between different cattle groups reduces pathogen spread.

Arrival management protocols for feedlot cattle address the high-risk period when most TEME cases occur. Processing procedures should include vaccination if not already current, with recognition that protection requires time to develop. Metaphylactic antibiotic treatment at arrival has been shown to reduce Histophilus somni disease incidence in some studies. Close monitoring during the first three weeks after arrival enables early detection and treatment. Adequate pen space, clean bedding, and environmental comfort support animal health during the adaptation period.

Health monitoring programs allow early detection of problems and assessment of prevention program effectiveness. Daily observation of cattle for signs of illness enables early intervention. Regular review of mortality records identifies patterns that may indicate Histophilus somni problems. Necropsy of fatal cases provides specific diagnostic information to guide management. Tracking treatment rates and outcomes measures the burden of disease and response to prevention efforts. These data support continuous improvement of health management programs.

Daily management in operations with Histophilus somni risk should incorporate routine observation practices that enable early disease detection. Cattle should be observed at least once daily, with particular attention to animals showing any sign of depression, isolation from pen mates, or reduced feed intake. The classic sleeper presentation may be subtle initially, and finding cattle standing apart with lowered heads and dull expressions warrants closer evaluation. Any febrile cattle should be considered potentially affected. In high-risk periods such as the weeks following feedlot arrival, increased observation frequency improves early detection.

Facility management influences Histophilus somni disease risk through effects on stress, transmission, and environmental conditions. Adequate pen space reduces stress from overcrowding and limits close contact transmission. Clean, dry bedding supports animal comfort and health. Proper ventilation in enclosed facilities reduces respiratory pathogen concentration. Water availability and cleanliness ensures adequate hydration. Feed delivery systems that provide consistent access reduce competition stress. Hospital and isolation facilities allow separation of sick animals for treatment and to limit transmission.

Herd health programs should address Histophilus somni as part of comprehensive respiratory disease management. Vaccination protocols should be established with veterinary guidance, tailored to the operation's risk factors and cattle sourcing. Written treatment protocols enable prompt and appropriate response when disease occurs. Training programs ensure that personnel can recognize early signs and implement treatment protocols. Regular veterinary review of health records and mortality data guides program refinement.

Record keeping supports Histophilus somni management by documenting disease occurrence and treatment outcomes. Individual animal health records track vaccinations, treatments, and responses. Mortality records with post-mortem findings when available identify the causes of death affecting the operation. Treatment records document drug usage, doses, and withdrawal periods. These data support both individual animal management and operation-level assessment of disease control effectiveness.

Economic considerations for Histophilus somni management include both prevention costs and disease impact. Vaccination program costs must be weighed against the value of animals protected and expected disease reduction. Metaphylactic antibiotics involve significant drug costs but may be justified by reduced morbidity and mortality. The economic impact of clinical disease includes treatment costs, mortality losses, reduced performance in recovered animals, and extended feeding through withdrawal periods. Analysis of these factors guides resource allocation between prevention and treatment capacity.

Risk for Histophilus somni disease relates primarily to management factors and exposure rather than breed genetics, affecting all cattle breeds under appropriate conditions. However, cattle in different production systems face different risk levels based on their typical management. Feedlot cattle of any breed face elevated risk during the high-stress arrival period. Dairy calves raised in group housing experience exposure and stress conditions that increase susceptibility. Beef cattle under extensive management may have lower exposure but also less immunity from natural exposure.

Production type considerations influence Histophilus somni risk primarily through effects on stress, commingling, and management intensity. Feedlot operations receiving cattle from multiple sources face the highest risk due to the combination of transportation stress, commingling of naive and exposed animals, and dietary transitions. Dairy heifer raising operations with group housing face similar risk factors. Cow-calf operations under extensive management face lower risk from TEME specifically but may experience other manifestations of Histophilus somni disease including reproductive losses.

Genetic selection has limited direct application to Histophilus somni prevention since susceptibility is primarily determined by management and exposure factors. However, general selection for disease resistance, immune function, and stress tolerance may produce animals better able to withstand the challenges that trigger Histophilus somni disease. Cattle with better adaptation to feedlot conditions may experience less physiological stress. Breeding for temperament may reduce stress responses during handling and transportation. These indirect genetic approaches complement but cannot replace management-based prevention.

Conditions commonly associated with Histophilus somni include other components of the bovine respiratory disease complex and other manifestations of Histophilus infection itself. Bacterial and viral respiratory infections frequently occur alongside or predisposing to Histophilus somni disease, with viral damage to mucosal barriers enabling bacterial invasion. Mycoplasma bovis causes similar neurological disease and may occur concurrently. Other manifestations of Histophilus somni infection including polyarthritis, myocarditis, and reproductive disease may occur in the same animals or concurrently in herd mates, reflecting the systemic nature of infection.

Conditions presenting similarly to TEME require differentiation for appropriate management. Listeriosis causes neurological disease in cattle but typically with slower onset, more prominent brainstem signs, and association with silage feeding. Rabies must always be considered in neurological cases, particularly in unvaccinated animals. Lead poisoning produces neurological signs with different historical context and without fever. Polioencephalomalacia causes depression and neurological signs but responds to thiamine and lacks the systemic illness and fever of TEME. Thromboembolism from other sources including endocarditis may produce focal neurological signs.

Complications of Histophilus somni neurological disease reflect both the systemic nature of infection and the consequences of the clinical course. Concurrent myocarditis may cause cardiac arrhythmias or failure even in animals surviving the neurological crisis. Polyarthritis may cause lasting lameness in survivors. Pneumonia from primary Histophilus involvement or secondary aspiration complicates recovery. Sequelae of prolonged recumbency including muscle damage and pressure necrosis affect animals down for extended periods. Reproductive consequences including infertility and abortion may follow systemic infection. These complications may require specific treatment beyond antibiotic therapy for the primary infection.